Ceretype Neuromedicine

BiotechnologySeedCambridge, USceretype.com

Latest round

Seed

Last raised

Jan 2024

Total raised

$2M

Investors

3

About Ceretype Neuromedicine

Founded in 2020 and based in Massachusetts, US, Ceretype Neuromedicine, Inc. operates as a neuropsychiatric drug development company that develops therapeutics for psychiatric patients. The company was founded by its CEO, Emily Stern, and David Silbersweig. In January 2024, Ceretype Neuromedicine, Inc. Ceretype Neuromedicine offers a functional magnetic resonance imaging (fMRI) platform, which is a brain imaging technology platform that provides biologically based therapeutic insights for patients with psychiatric and neurological disorders. The company also offers brain insight reports, or functional brain maps, which give each patient unique insights that may help develop biomarkers for psychiatric and neurological conditions.

Who invested in Ceretype Neuromedicine

3 investors across 1 round

See all investors in Ceretype Neuromedicine

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Jan 4, 2024

    Amount

    $2M

    Investors

    Locked

Questions about Ceretype Neuromedicine

Who invested in Ceretype Neuromedicine?

Ceretype Neuromedicine has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Ceretype Neuromedicine raised?

Ceretype Neuromedicine has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Ceretype Neuromedicine last raise money?

Ceretype Neuromedicine's most recent round on record is a Seed, in Jan 2024.

What does Ceretype Neuromedicine do?

Founded in 2020 and based in Massachusetts, US, Ceretype Neuromedicine, Inc.

Where is Ceretype Neuromedicine headquartered?

Ceretype Neuromedicine is headquartered in Cambridge, US.

Which VCs invest in companies like Ceretype Neuromedicine?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ceretype Neuromedicine's stage. Their profiles are linked below.

Raising like Ceretype Neuromedicine? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.